Advertisement

Current Fungal Infection Reports

, Volume 7, Issue 4, pp 287–292 | Cite as

Epidemiology of Mucormycosis in India

  • Arunaloke ChakrabartiEmail author
  • Manpreet Dhaliwal
Epidemiological Aspects of Fungal Infection (T Chiller and J Baddley, Section Editors)

Abstract

Mucormycosis is an emerging healthcare problem in the Indian population. The epidemiology of the disease is distinct with very high incidence among uncontrolled diabetics. The patients present commonly as rhino-orbito-cerebral mucormycosis, which is easy to diagnose. But, the mortality rate remains high (nearly 50 %), as the patients attend the healthcare facility late in the course of the disease after extensive spread of infection. Isolated renal mucormycosis in young apparently healthy individuals is a new form of the disease. The spectrum of etiological agents causing mucormycosis is also unique as Apophysomyces elegans is the second most common pathogen after Rhizopus oryzae. Many new agents are identified causing the disease.

Keywords

Mucormycosis Zygomycosis Epidemiology Diabetes Renal disease Mucoraceous fungi Apophysomyces elegans Rhizopus Nosocomial Transplant Hematology Immunocompetent host Computational model 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

A Chakrabarti declares no conflicts of interest.

M Dhaliwal declares no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23–34. This review details the emerging epidemiology and the clinical forms of mucormycosis and highlights the difference of epidemiology between the two regions.PubMedCrossRefGoogle Scholar
  2. 2.
    Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Sugar AM. Agents of mucormycosis and related species. In: Mandell G, Bennett J, Dolin R, editors. Principles and practices of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 2311–21.Google Scholar
  4. 4.
    •Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S44–54. This paper documents all healthcare procedure associated mucormycosis, which is an emerging problem in hospitals.PubMedCrossRefGoogle Scholar
  5. 5.
    Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44:335–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Chakrabarti A, Chatterjee SS, Das A, et al. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J. 2009;85:573–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Al-Ajam MR, Bizri AR, Mokhbat J, et al. Mucormycosis in the Eastern Mediterranean: a seasonal disease. Epidemiol Infect. 2006;134:341–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Funada H, Matsuda T. Pulmonary mucormycosis in a hematology ward. Intern Med. 1996;35:540–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Shpitzer T, Keller N, Wolf M, et al. Seasonal variations in rhino-cerebral Mucor infection. Ann Otol Rhinol Laryngol. 2005;114:695–8.Google Scholar
  10. 10.
    Nithyanandam S, Jacob MS, Battu RR, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51:231–6.PubMedGoogle Scholar
  11. 11.
    Chakrabarti A, Das A, Sharma A, et al. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect. 2001;42:261–6.PubMedCrossRefGoogle Scholar
  12. 12.
    •• Marak RS, Misra R, Ansari MS, et al. Successful medical management of renal zygomycosis: a summary of two cases and a review of the Indian literature. Med Mycol. 2010;48:1088–95. This review deals with isolated renal mucormycosis problem, its epidemiology, diagnosis and management.PubMedCrossRefGoogle Scholar
  13. 13.
    Diwakar A, Dewan RK, Chowdhary A, et al. Zygomycosis–a case report and overview of the disease in India. Mycoses. 2007;50:247–54.PubMedCrossRefGoogle Scholar
  14. 14.
    Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10 Suppl 1:31–47.PubMedCrossRefGoogle Scholar
  15. 15.
    Chakravarti A, Bhargava R, Bhattacharya S. Cutaneous mucormycosis of nose and facial region in children: a case series. Int J Pediatr Otorhinolaryngol. 2013;77:869–72.PubMedCrossRefGoogle Scholar
  16. 16.
    Chander J, Kaur J, Attri A, et al. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J Med Res. 2010;131:765–70.PubMedGoogle Scholar
  17. 17.
    Ramesh V, Ramam M, Capoor MR, et al. Subcutaneous zygomycosis: report of 10 cases from two institutions in North India. J Eur Acad Dermatol Venereol. 2010;24:1220–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Bhansali A, Bhadada S, Sharma A, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004;80:670–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Godara SM, Kute VB, Goplani KR, et al. Mucormycosis in renal transplant recipients: predictors and outcome. Saudi J Kidney Dis Transpl. 2011;22:751–6.PubMedGoogle Scholar
  20. 20.
    Patra S, Vij M, Chirla DK, et al. Unsuspected invasive neonatal gastrointestinal mucormycosis: a clinicopathological study of six cases from a tertiary care hospital. J Indian Assoc Pediatr Surg. 2012;17:153–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Yamazaki T, Kume H, Murase S, et al. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol. 1999;37:1732–8.PubMedGoogle Scholar
  22. 22.
    Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006;91:986–9.PubMedGoogle Scholar
  23. 23.
    • Chakrabarti A, Sood P, Denning D. Estimating fungal infection burden in India using computational models: Mucormycosis burden as a case study [Poster number 1044]. Presented at the 23rd ECCMID conference. Berlin, Germany; April 27–30, 2013. This poster elucidates mucormycosis burden in India using a contextual computational model.Google Scholar
  24. 24.
    Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009;15:1395–401.PubMedCrossRefGoogle Scholar
  25. 25.
    Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005;191:1350–60.Google Scholar
  26. 26.
    Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37:221–9.Google Scholar
  27. 27.
    Stelzmueller I, Lass-Floerl C, Geltner C, et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int. 2008;21:534–46.PubMedCrossRefGoogle Scholar
  28. 28.
    • Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–67. This paper highlights the epidemiology of mucormycosis in Europe.PubMedCrossRefGoogle Scholar
  29. 29.
    Saegeman V, Maertens J, Meersseman W, et al. Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg Infect Dis. 2010;16:1456–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Pagano L, Valentini CG, Posteraro B, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21:322–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Kontoyiannis DP. Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis. 2007;44:1089–90.PubMedCrossRefGoogle Scholar
  32. 32.
    The IDF Diabetes Atlas. 4th ed. Brussels: International Diabetes Federation; 2009.Google Scholar
  33. 33.
    Ingram CW, Sennesh J, Cooper JN, et al. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis. 1989;11:741–54.PubMedCrossRefGoogle Scholar
  34. 34.
    Weng DE, Wilson WH, Little R, et al. Successful medical management of isolated renal zygomycosis: case report and review. Clin Infect Dis. 1998;26:601–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Chugh KS, Sakhuja V, Gupta KL, et al. Renal mucormycosis: computerized tomographic findings and their diagnostic significance. Am J Kidney Dis. 1993;22:393–7.PubMedGoogle Scholar
  36. 36.
    Gupta KL, Radotra BD, Sakhuja V, et al. Mucormycosis in patients with renal failure. Ren Fail. 1989;11:195–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Gupta KL, Joshi K, Sud K, et al. Renal zygomycosis: an under-diagnosed cause of acute renal failure. Nephrol Dial Transplant. 1999;14:2720–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Chakrabarti A, Ghosh A, Prasad GS, et al. Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol. 2003;41:783–8.Google Scholar
  39. 39.
    Singh SK, Wadhwa P, Sakhuja V. Isolated bilateral renal mucormycosis. Urology. 2004;63:979–80.PubMedCrossRefGoogle Scholar
  40. 40.
    Sharma R, Shivanand G, Kumar R, et al. Isolated renal mucormycosis: an unusual cause of acute renal infarction in a boy with aplastic anaemia. Br J Radiol. 2006;79:e19–21.PubMedCrossRefGoogle Scholar
  41. 41.
    Thomas AJ, Shah S, Mathews MS, et al. Apophysomyces elegans - renal mucormycosis in a healthy host: a case report from south India. Indian J Med Microbiol. 2008;26:269–71.Google Scholar
  42. 42.
    Dhua AK, Sinha S, Sarin YK, et al. Isolated mucormycosis in a post-pyeloplasty kidney in an immuno-competent child. J Indian Assoc Pediatr Surg. 2012;17:132–4.PubMedCrossRefGoogle Scholar
  43. 43.
    Khandelwal D, Gadodia A, Sood R, et al. Disseminated zygomycosis with renal involvement simulating malignancy in a diabetic patient. Indian J Urol. 2012;28:347–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Jianhong L, Xianliang H, Xuewu J. Isolated renal mucormycosis in children. J Urol. 2004;171:387–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Lin CY, Lee SC, Lin CC, et al. Isolated fatal renal mucormycosis in a patient with chronic obstructive pulmonary disease and tuberculosis. Int J Clin Pract. 2003;57:916–8.PubMedGoogle Scholar
  46. 46.
    Yu J, Li RY. Primary renal zygomycosis due to Rhizopus oryzae. Med Mycol. 2006;44:461–6.Google Scholar
  47. 47.
    Gupta KL, Khullar DK, Behera D, et al. Pulmonary mucormycosis presenting as fatal massive haemoptysis in a renal transplant recipient. Nephrol Dial Transplant. 1998;13:3258–60.PubMedCrossRefGoogle Scholar
  48. 48.
    Gupta K, Nada R, Joshi K, et al. Can ascending infection from bladder serve as the portal of entry for primary renal zygomycosis? Mycopathologia. 2010;170:357–60.PubMedCrossRefGoogle Scholar
  49. 49.
    Misra PC, Srivastava KJ, Lata K. Apophysomyces, a new genus of the Mucorales. Mycotaxon. 1979;8:377–82.Google Scholar
  50. 50.
    Meis JF, Chakrabarti A. Changing epidemiology of an emerging infection: zygomycosis. Clin Microbiol Infect. 2009;15 Suppl 5:10–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Cooter RD, Lim IS, Ellis DH, et al. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol. 1990;28:2151–3.Google Scholar
  52. 52.
    •• Chakrabarti A, Shivaprakash MR, Curfs-Breuker I, et al. Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern. J Clin Microbiol. 2010;48:4580–5. This is a detailed study on the strain typing, in-vitro antifungal susceptibility and clinical manifestations of the diseases caused by Apophysomyces elegans in India.Google Scholar
  53. 53.
    Alvarez E, Stchigel AM, Cano J, et al. Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev Iberoam Micol. 2010;27:80–9.Google Scholar
  54. 54.
    Padhye AA, Ajello L. Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J Clin Microbiol. 1988;26:1861–3.Google Scholar
  55. 55.
    Chakrabarti A, Marak RS, Shivaprakash MR, et al. Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus. J Clin Microbiol. 2010;48:1965–9.Google Scholar
  56. 56.
    Hemashettar BM, Patil RN, O'Donnell K, et al. Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India. J Clin Microbiol. 2011;49:2372–5.Google Scholar
  57. 57.
    Sivakumar S, Mathews MS, George B. Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India. Mycoses. 2005;48:360–2.Google Scholar
  58. 58.
    Xess I, Mohapatra S, Shivaprakash MR, et al. Evidence implicating Thamnostylum lucknowense as an etiological agent of rhino-orbital mucormycosis. J Clin Microbiol. 2012;50:1491–4.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Medical MicrobiologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations